Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > RMD timing

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Dec 17, 2022 4:42pm

129 Views

Post# 35177900

RE:RE:RE:RE:RE:RE:RE:RE:RMD timing

THTX has become a reverse Gamestop for the time being. An illiquid micro scrap targeted by low life shorts whit no support from it's burned.. I meen broiled shareholders and institutions that are now only interested in an exit strategy. The Nash and Th1902 might be succesful one day but it won't be in our hands at that point in time.. just like Kiadis and Theralux. Someone in Pharma expalined to me that the Pharma business is down and dirty and require more money and brown envelops for trial centers and FDA than Thera will ever have. Cash poor Thera probably ends up with patients nobody else want's because they are to finished to get any king of positive outcome.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in